Man Group’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $386M | Sell |
1,774,415
-34,292
| -2% | -$7.61M | 0.7% | 12 |
|
|
2025
Q4 | $413M | Buy |
1,808,707
+518,767
| +40% | +$118M | 0.7% | 14 |
|
|
2025
Q3 | $299M | Buy |
1,289,940
+254,429
| +25% | +$51.8M | 0.52% | 24 |
|
|
2025
Q2 | $192M | Buy |
1,035,511
+423,451
| +69% | +$78.7M | 0.37% | 46 |
|
|
2025
Q1 | $128M | Sell |
612,060
-161,966
| -21% | -$31.5M | 0.33% | 60 |
|
|
2024
Q4 | $138M | Sell |
774,026
-47,301
| -6% | -$8.7M | 0.36% | 41 |
|
|
2024
Q3 | $162M | Sell |
821,327
-61,637
| -7% | -$11.5M | 0.42% | 33 |
|
|
2024
Q2 | $151M | Sell |
882,964
-367,300
| -29% | -$60.8M | 0.38% | 38 |
|
|
2024
Q1 | $228M | Buy |
1,250,264
+10,515
| +0.8% | +$1.81M | 0.57% | 20 |
|
|
2023
Q4 | $192M | Buy |
+1,239,749
| New | +$181M | 0.54% | 23 |
|
|
2023
Q3 | – | Sell |
-872,821
| Closed | -$128M | – | 18 |
|
|
2023
Q2 | $118M | Buy |
+872,821
| New | +$128M | 0.36% | 44 |
|
|
2023
Q1 | – | Sell |
-480,672
| Closed | -$73.5M | – | 87 |
|
|
2022
Q4 | $77.7M | Buy |
480,672
+227,138
| +90% | +$34.8M | 0.28% | 72 |
|
|
2022
Q3 | $34M | Buy |
+253,534
| New | +$36.4M | 0.16% | 160 |
|
|
2022
Q2 | – | Sell |
-389,831
| Closed | -$59.6M | – | 94 |
|
|
2022
Q1 | $63.2M | Buy |
389,831
+52,279
| +15% | +$7.59M | 0.22% | 100 |
|
|
2021
Q4 | $45.7M | Buy |
337,552
+4,080
| +1% | +$482K | 0.15% | 152 |
|
|
2021
Q3 | $36M | Buy |
333,472
+29,045
| +10% | +$3.32M | 0.13% | 176 |
|
|
2021
Q2 | $34.3M | Sell |
304,427
-117,301
| -28% | -$13.2M | 0.12% | 177 |
|
|
2021
Q1 | $45.6M | Sell |
421,728
-287,672
| -41% | -$30.8M | 0.2% | 113 |
|
|
2020
Q4 | $76M | Sell |
709,400
-816,393
| -54% | -$78.5M | 0.33% | 56 |
|
|
2020
Q3 | $134M | Sell |
1,525,793
-219,350
| -13% | -$20.7M | 0.53% | 29 |
|
|
2020
Q2 | $171M | Sell |
1,745,143
-137,133
| -7% | -$12.1M | 0.86% | 17 |
|
|
2020
Q1 | $143M | Sell |
1,882,276
-1,137,749
| -38% | -$96.9M | 0.93% | 15 |
|
|
2019
Q4 | $267M | Sell |
3,020,025
-19,813
| -0.7% | -$1.64M | 0.88% | 9 |
|
|
2019
Q3 | $230M | Buy |
3,039,838
+434,570
| +17% | +$29.8M | 0.86% | 9 |
|
|
2019
Q2 | $189M | Buy |
2,605,268
+1,636,248
| +169% | +$129M | 0.68% | 14 |
|
|
2019
Q1 | $78.1M | Buy |
969,020
+839,173
| +646% | +$68.7M | 0.3% | 59 |
|
|
2018
Q4 | $12M | Sell |
129,847
-25,553
| -16% | -$2.25M | 0.05% | 399 |
|
|
2018
Q3 | $14.7M | Sell |
155,400
-16,777
| -10% | -$1.59M | 0.05% | 441 |
|
|
2018
Q2 | $16M | Sell |
172,177
-895,883
| -84% | -$87.5M | 0.07% | 342 |
|
|
2018
Q1 | $101M | Buy |
+1,068,060
| New | +$117M | 0.46% | 35 |
|
Other funds holding ABBV
VCM
VPM
Man Group's ABBV Position: Q1 2026 in Review
Man Group reduced its AbbVie (ABBV) stake by 1.9% in Q1 2026, selling an estimated $7.61M and leaving 1,774,415 shares worth $386M. The position accounts for 0.7% of the portfolio, ranked #12.
Man Group first reported a position in ABBV in Q1 2018 and has held it in 30 quarters since. The position peaked at $413M in Q4 2025. 4,080 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.
- Man Group held 1,774,415 shares of AbbVie worth $386M as of Q1 2026.
- Man Group sold 34,292 AbbVie shares in Q1 2026, an estimated $7.61M.
- AbbVie made up 0.7% of Man Group's portfolio in Q1 2026, its #12 holding.
- Man Group first reported a position in AbbVie in Q1 2018 and has held it in 30 quarters since.
- Man Group's AbbVie position peaked at $413M in Q4 2025.
- 4,080 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.
Based on Man Group's 13F filing for Q1 2026, filed 15 May 2026.